Siemens Healthineers receives Frost & Sullivan Award for Precision Imaging
Siemens Healthineers’ Precision Imaging recognized with Global Visionary Innovation Leadership Award 2019
Siemens Healthineers received this Award for our leading efforts in establishing imaging as an active contributor to precision medicine. We are proud to be recognized as thought leaders in precision medicine and to see that our efforts to provide high-value care and to improve patient outcomes are advancing healthcare. This underlines the impact forward-thinking ideas and solutions have on the far-reaching changes currently taking place throughout the healthcare system. Our goal: the right treatment at the right time for every patient.
Siemens Healthineers is said to be pushing boundaries in precision medicine with its visionary developments and solutions:
- Boasting PET-CT quantification capabilities, which enable accuracy when imaging a tumor to determine its size, location, and volume
- Developing BioMatrix technology on its magnetic resonance imaging (MRI) platforms, featuring respiratory and kinetic sensors
- Enabling personalized medicine with real-time ultrasound imaging and innovative applications adapted to individual patient
- Integrating data and supporting decisions along the clinical pathway, with artificial intelligence built into its AI-Pathway Companion
Frost & Sullivan also emphasize that Siemens Healthineers is taking a holistic view of its wide portfolio, pulling all capabilities together to enable this effort from diagnosis to therapy. The personnel in charge of leading this effort have a cross-portfolio view of how all the verticals can contribute to this paradigm.
About the Award
Frost & Sullivan presents this award to companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development.
Get more insights on precision medicine and our awarded solutions: